DOW JONES23,184.41+530.55 2.34%
S&P 5002,717.17+57.76 2.17%
NASDAQ8,042.71+155.45 1.97%

Caladrius Biosciences Q4 EPS $(0.47) Misses $(0.34) Estimate

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.34) by 38.24 percent. This is a 30.56 percent decrease over losses of $(0.36) per

Benzinga · 03/05/2020 21:12

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.34) by 38.24 percent. This is a 30.56 percent decrease over losses of $(0.36) per share from the same period last year.